AV7909 + BioThrax
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Anthrax
Conditions
Anthrax
Trial Timeline
Jan 1, 2013 → Dec 1, 2014
NCT ID
NCT01770743About AV7909 + BioThrax
AV7909 + BioThrax is a phase 2 stage product being developed by Emergent BioSolutions for Anthrax. The current trial status is completed. This product is registered under clinical trial identifier NCT01770743. Target conditions include Anthrax.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03877926 | Phase 3 | Completed |
| NCT01770743 | Phase 2 | Completed |
Competing Products
15 competing products in Anthrax